Pär Ewing
Impact in
- Pharmaceutical Science top 5%
- Drug Solubulity and Delivery Systems
- Advanced Drug Delivery Systems
-
- Inhalation and Respiratory Drug Delivery
- Neonatal Respiratory Health Research
Papers in
-
- Inhalation and Respiratory Drug Delivery 10
-
- Asthma and respiratory diseases 5
- Co-authors
- Per Gerde (6 shared papers)Markus Fridén (4 shared papers)Åke Ryrfeldt (3 shared papers)Anders Lundqvist (3 shared papers)Neil D. Evans (2 shared papers)Göran Lidén (1 shared paper)Lena Låstbom (1 shared paper)Maria Malmlöf (1 shared paper)
- Journals
- EJNMMI Research (2 papers)Journal of Aerosol Medicine and Pulmonary Drug Delivery (2 papers)Journal of Pharmacology and Experimental Therapeutics (1 paper)Inhalation Toxicology (1 paper)Pharmaceutics (1 paper)
- Partner nations
- SwedenUnited KingdomUnited States
In The Last Decade
Pär Ewing
17 papers receiving 378 citations
Peers
Comparison fields: 5 of 82
- Pharmaceutical Science 103
- Pulmonary and Respiratory Medicine 265
- Physiology 83
- Pharmacology 19
- Food Science 37
Countries citing papers authored by Pär Ewing
This map shows the geographic impact of Pär Ewing's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pär Ewing with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pär Ewing more than expected).
Fields of papers citing papers by Pär Ewing
This network shows the impact of papers produced by Pär Ewing. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pär Ewing. The network helps show where Pär Ewing may publish in the future.
Co-authors
The 25 scholars most cited alongside Pär Ewing, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 62 | |
| 2 | 2021 | 43 | |
| 3 | 2017 | 41 | |
| 4 | 2004 | 40 | |
| 5 | 2015 | 38 | |
| 6 | 2012 | 36 | |
| 7 | 2013 | 35 | |
| 8 | 2007 | 26 | |
| 9 | 2020 | 19 | |
| 10 | 2015 | 15 | |
| 11 | 2009 | 10 | |
| 12 | 2019 | 10 | |
| 13 | Pharmacokinetics of intravenously and orally administered pyrimethamine in horses. | 1992 | 10 |
| 14 | 2020 | 4 | |
| 15 | 2019 | 3 | |
| 16 | 2020 | 2 | |
| 17 | 2023 | 1 |
About Pär Ewing
Pär Ewing is a scholar working on Pulmonary and Respiratory Medicine, Physiology, Pharmaceutical Science, Pharmacology and Health, Toxicology and Mutagenesis, having authored 17 papers that have together received 395 indexed citations. Recurring topics across this work include Inhalation and Respiratory Drug Delivery (10 papers), Asthma and respiratory diseases (5 papers), Drug Solubulity and Delivery Systems (3 papers), Drug-Induced Hepatotoxicity and Protection (2 papers), Pharmacological Effects and Assays (2 papers), Air Quality and Health Impacts (2 papers), Pharmacogenetics and Drug Metabolism (1 paper) and Cardiac electrophysiology and arrhythmias (1 paper). The work is most often cited by research in Pharmaceutical Science (103 citations), Pulmonary and Respiratory Medicine (265 citations), Physiology (83 citations), Pharmacology (19 citations) and Food Science (37 citations). Pär Ewing has collaborated with scholars based in Sweden, United Kingdom and United States. Frequent co-authors include Per Gerde, Markus Fridén, Åke Ryrfeldt, Anders Lundqvist, Neil D. Evans, Göran Lidén, Lena Låstbom, Maria Malmlöf, Stefan Eirefelt and Katarina Ekelund. Their work appears in journals such as EJNMMI Research, Journal of Aerosol Medicine and Pulmonary Drug Delivery, Journal of Pharmacology and Experimental Therapeutics, Inhalation Toxicology and Pharmaceutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.